~~<i id='EC87DDCB54'><strike id='EC87DDCB54'><tt id='EC87DDCB54'><pre id='EC87DDCB54'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：hotspot 2025-09-29 19:39:19 Page View：9

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Ahead of JPM, here's who's profiting most in health care
Next article： What does generative AI mean for health care? We asked experts

explore

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

Goldman Sachs launches $650M fund for life science investments

AdobeInvestmentbankGoldmanSachsisjumpingintothebiotechworldafterraising$650milliontoinvestinprivatel